Kohlberg Kravis Roberts & Co. L.P. - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 210 filers reported holding BRIDGEBIO PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
Kohlberg Kravis Roberts & Co. L.P. ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$819,077,805
+53.3%
31,060,9710.0%28.79%
+74.0%
Q2 2023$534,248,701
+3.7%
31,060,9710.0%16.54%
+6.7%
Q1 2023$514,990,899
+117.6%
31,060,9710.0%15.50%
+94.0%
Q4 2022$236,684,599
-23.3%
31,060,9710.0%7.99%
+28.8%
Q3 2022$308,746,000
+9.5%
31,060,9710.0%6.20%
+65.4%
Q2 2022$282,034,000
-10.5%
31,060,9710.0%3.75%
+31.2%
Q1 2022$315,269,000
-39.1%
31,060,9710.0%2.86%
+0.6%
Q4 2021$518,097,000
-64.4%
31,060,9710.0%2.84%
-60.9%
Q3 2021$1,455,828,000
-23.1%
31,060,9710.0%7.26%
-5.4%
Q2 2021$1,893,477,000
-1.0%
31,060,9710.0%7.68%
-20.3%
Q1 2021$1,913,356,000
-22.0%
31,060,971
-10.0%
9.64%
-22.6%
Q4 2020$2,454,075,000
+89.5%
34,510,9710.0%12.45%
+68.4%
Q3 2020$1,294,852,000
+15.1%
34,510,9710.0%7.40%
+7.7%
Q2 2020$1,125,403,000
+5.2%
34,510,971
-6.5%
6.87%
+0.6%
Q1 2020$1,070,119,000
-17.3%
36,900,6610.0%6.83%
+8.0%
Q4 2019$1,293,368,000
+63.3%
36,900,6610.0%6.32%
+41.9%
Q3 2019$792,257,000
-20.4%
36,900,6610.0%4.46%
-63.7%
Q2 2019$995,211,00036,900,66112.26%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders